下肢静脈瘤治療の市場規模、シェア、成長分析：タイプ別、製品別、最終用途別、地域別 - 産業予測 2024～2031年

下肢静脈瘤治療市場規模は2023年に13億8,000万米ドルと評価され、2024年の14億7,000万米ドルから2032年には24億米ドルに成長し、予測期間（2025～2032年）のCAGRは6.32％で成長する見通しです。

世界の下肢静脈瘤治療市場は著しい成長を遂げており、高齢化、座りがちなライフスタイル、肥満によってこの一般的な疾患の有病率が増加しているため、今後も拡大が続くと予測されています。市場は、従来の手術に比べて痛みの軽減や回復時間の短縮などの利点を提供する、内因性レーザーアブレーション、硬化療法、高周波アブレーションなどの低侵襲治療へとシフトしています。超音波ガイド下泡沫硬化療法を含む最近の技術的進歩は、患者の転帰と満足度を高めています。しかし、保険償還の問題、高額な治療費、不十分な認知度といった課題は、特に発展途上地域におけるアクセシビリティを制限する可能性があります。競合情勢は、各社が技術革新に注力するにつれて激化しており、新しいソリューションを効果的に市場に投入するためには、調査や規制順守への継続的な投資が必要です。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

下肢静脈瘤治療市場規模：タイプ別

• 市場概要
• 静脈内アブレーション
  • 静脈内レーザー治療
  • 高周波アブレーション
• 注射硬化療法
• 外科的結紮とストリッピング

下肢静脈瘤治療市場規模：製品別

• 市場概要
• アブレーション装置
• 高周波アブレーション装置
• レーザーアブレーション装置
• 静脈閉鎖製品

下肢静脈瘤治療市場規模：最終用途別

• 市場概要
• 病院
• 外来手術センター
• 専門クリニック

下肢静脈瘤治療市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Medtronic plc（Ireland）
• AngioDynamics, Inc.（USA）
• Teleflex Incorporated（USA）
• Boston Scientific Corporation（USA）
• Lumenis Ltd.（Israel）
• Quanta System S.p.A.（Italy）
• Biolitec AG（Austria）
• Dornier MedTech GmbH（Germany）
• Sciton, Inc.（USA）
• Fotona d.o.o.（Slovenia）
• Viatris Inc.（USA）
• Merz Aesthetics（USA）
• SIGVARIS Group（Switzerland）
• Essity Aktiebolag（publ）（Sweden）
• F Care Systems NV（Belgium）
• VVT Medical（Israel）
• Alma Lasers（Israel）
• Energist Group（UK）.
• Eufoton s.r.l.（Italy）
• WONTECH Co., Ltd.（South Korea）

結論と推奨事項

Varicose Veins Treatment Market size was valued at USD 1.38 Billion in 2023 and is poised to grow from USD 1.47 Billion in 2024 to USD 2.4 Billion by 2032, growing at a CAGR of 6.32% during the forecast period (2025-2032).

The global varicose veins treatment market is witnessing remarkable growth and is projected to continue its expansion due to the increasing prevalence of this common condition, spurred by an aging population, sedentary lifestyles, and obesity. The market is shifting towards minimally invasive treatments like endogenous laser ablation, sclerotherapy, and radiofrequency ablation, which offer benefits such as reduced pain and shorter recovery times compared to traditional surgery. Recent technological advancements, including ultrasound-guided foam sclerotherapy, are enhancing patient outcomes and satisfaction. However, challenges such as reimbursement issues, high treatment costs, and inadequate awareness can limit accessibility, particularly in developing regions. The competitive landscape is intensifying as companies focus on innovation, necessitating ongoing investment in research and regulatory compliance to bring new solutions to market effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Varicose Veins Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Varicose Veins Treatment Market Segmental Analysis

Global Varicose Veins Treatment Market is segmented by type, products, end use and region. Based on type, the market is segmented into endovenous ablation, injection sclerotherapy and surgical ligation & stripping. Based on products, the market is segmented into ablation devices, radiofrequency ablation devices, laser ablation devices and venous closure products. Based on end use, the market is segmented into hospitals, ambulatory surgical centers and specialty clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Varicose Veins Treatment Market

The Varicose Veins Treatment market is being propelled by a surge in awareness and education concerning varicose veins and the treatment options available. With public awareness campaigns, educational initiatives, and the widespread dissemination of information through various platforms, more individuals are becoming informed about their conditions. This increased knowledge empowers patients to take action and seek appropriate treatment for their varicose veins. As a result, the combination of heightened awareness and patient education is fostering a growing demand in the market, leading to an increase in the number of individuals pursuing effective treatment solutions to address their varicose vein issues.

Restraints in the Varicose Veins Treatment Market

The varicose veins treatment market faces significant restraints due to regulatory challenges. Manufacturers must navigate complex regulatory requirements and approval processes, which can vary widely across different countries. This intricacy can lead to delays and increased costs, hampering the timely introduction of new treatments and innovations. Consequently, the burden of regulatory compliance may deter companies from pursuing advancements in the field, ultimately limiting options for patients seeking effective solutions. As a result, the overall growth and development of the varicose veins treatment market may be adversely impacted, creating obstacles for both manufacturers and healthcare providers alike.

Market Trends of the Varicose Veins Treatment Market

The varicose veins treatment market is experiencing a significant shift towards combination therapies, which are becoming increasingly popular due to their ability to optimize treatment outcomes. Combining modalities like endovenous ablation with sclerotherapy allows for a comprehensive approach, effectively targeting various facets of venous disease. This trend not only enhances the efficacy of treatments but also boosts patient satisfaction, leading to a more favorable perception of varicose vein options. As healthcare providers look to maximize results and improve the overall patient experience, the adoption of combination therapies is expected to drive market growth and innovation in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Varicose Veins Treatment Market Size by Type & CAGR (2025-2032)

• Market Overview
• Endovenous Ablation
  • Endovenous Laser Therapy
  • Radiofrequency Ablation
• Injection Sclerotherapy
• Surgical Ligation & Stripping

Global Varicose Veins Treatment Market Size by Products & CAGR (2025-2032)

• Market Overview
• Ablation Devices
• Radiofrequency Ablation Devices
• Laser Ablation Devices
• Venous Closure Products

Global Varicose Veins Treatment Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Global Varicose Veins Treatment Market Size & CAGR (2025-2032)

• North America (Type, Products, End Use)
  • US
  • Canada
• Europe (Type, Products, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Products, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Products, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Products, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lumenis Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quanta System S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biolitec AG (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dornier MedTech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sciton, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fotona d.o.o. (Slovenia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz Aesthetics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SIGVARIS Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Essity Aktiebolag (publ) (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F Care Systems NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VVT Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alma Lasers (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Energist Group (UK).
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eufoton s.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WONTECH Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations